Toll Free: 1800 22 0369 / 1800 103 1369 Email Us: customercare@canmoney.in
Market

SUVEN PHARMACEUTICALS LTD.

  • NSE CodeSUVENPHAREQ
  • BSE Code543064
  • ISININE03QK01018
  • IndustryPharmaceuticals

Company Information

Management

Mr. K Hanumantha Rao

Co. Secretary & Compl. Officer

Mr. P Subba Rao

Chief Financial Officer

Incorporation Year

06/11/2018

Registered Address

Registered Office : 8-2-334, SDE Serene Chambers, , 3rd Floor, Road No. 5, Avenue 7, Banjara Hills,
Hyderabad, Telangana - 500034
Tel: 040-23549414, 23543311, 23543315
Fax: 040-23541142

Registrar Office

KFIN Technologies Pvt. Ltd.
Selenium Tower B, Plot No. 31-32,Gachibowli, Financial District, Nanakramguda,Serilingampally Man
Hyderabad,500032,Telangana
Tel: 040-67161500
Fax: 23420814

Email

khrao@suvenpharm.com

Website

http://www.suvenpharm.com

Listing

BSE, NSE

Corporate News

Suven Pharmaceutical has submitted to BSE the Shareho...

18-Jan-2021|6:30PM

As of December 2020, 60.00% is owned by Indian Promoters and 40.00% by Publ

Suven Pharmaceutical - Compliances-Certificate under ...

11-Jan-2021|4:36PM

Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regula

Suven Pharmaceutical - Announcement under Regulation ...

03-Dec-2020|11:25AM

We wish to inform you that management of Suven Pharma is giving corporate p

Suven Pharmaceutical - Announcement under Regulation ...

25-Nov-2020|4:08PM

We wish to inform you that management of Suven Pharma is giving corporate p

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug27.1063.37
Aarti Drug686.906,401.91
Abbott India14,576.0530,973.09
ABL Bio-Tech0.810.66
Add LifePhrm0.466.89

MF Holding

Scheme NameValue
(₹ Cr)
Holding (%)
L&T Emerg..125.092.18
L&T Midca..99.231.60
UTI Flexi Cap..67.010.45
L&T India..37.910.57
Edelweiss Sma..5.950.96

Board Meetings

DatePurpose
30/10/2020Quarterly Results
17/08/2020Quarterly Results &..
18/06/2020Audited Results